New Products

BALTIMORE — The Food and Drug Administration has approved a generic drug for insomnia made by Lupin, the drug maker said.

The FDA approved zolpidem tartrate extended-release tablets in the 6.25-mg and 12.5-mg strengths, a generic version of Sanofi's Ambien CR.

The branded version of the drug had sales of $366 million during the 12-month period ended in March, according to IMS Health.

JERUSALEM — The Food and Drug Administration has approved a new formulation of a cancer drug made by Teva Pharmaceutical Industries, Teva said Tuesday.

The Israeli drug maker announced the approval of a liquid formulation of Treanda (bendamustine hydrochloride), which it said would eliminate the need for reconstitution.

The drug is used to treat indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with Rituxan (rituximab), which is made by Genentech and Biogen Idec, and in patients with chronic lymphocytic leukemia.

TORONTO — Market saturation will drive down the market for electronic medical records in the United States despite a spike last year resulting from government incentive funding, according to a new study.

The Millennium Research Group predicts that due to Medicare penalties for hospitals and physicians that fail to demonstrate meaningful use of electronic medical records by 2015, most adoption will occur by then. But market saturation means that purchases of new systems will likely decline.

HYDERABAD, India — The Food and Drug Administration has approved an injected drug for the bone marrow disorder myelodysplastic syndrome made by Dr. Reddy's Labs, the company said Tuesday.

Dr. Reddy's announced the approval of azacitidine injection in the 100-mg-per-vial strength. The drug is a generic version of Celgene's Vidaza, and Dr. Reddy's plans to launch the product in the near future.

Vidaza had sales of about $378.5 million during the 12-month period ended in July, according to IMS Health.

LAKE FOREST, Ill. — Hefty announced on Tuesday a new trash bag with advanced odor-control, the company stated.

Hefty Ultimate with Arm & Hammer provides a trio of advanced technology to give the consumer everything needed in one bag. The Arm & Hammer patented odor-neutralizing technology helps eliminate kitchen odors. Hefty Ultimate bags come in scent-free, lavender and clean burst scents.

MOUNTAIN VIEW, Calif. — Speck, a designer of slim-fitting protective cases and covers for smartphones, tablets and laptops, on Tuesday announced a new iPhone case for the iPhone 5 and 5s.

NEW YORK — Stiefel has launched a new drug for treating acne, the company said Tuesday.

Stiefel, which is a subsidiary of British drug maker GlaxoSmithKline, announced the launch of Fabior (tazarotene) foam, which it called the only retinoid in a topical foam formulation for acne vulgaris in patients aged 12 and older.

The drug originally received Food and Drug Administration approval in May 2012.

PARIS — Sanofi US and its consumer health business Chattem on Monday unveiled plans to re-introduce the iconic Rolaids heartburn-relief brand to the U.S. market. The brand returns after a three-year hiatus in the marketplace and follows Chattem's acquisition of Rolaids earlier this year.